Efficacy and safety of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small-cell lung cancer: a systematic review and meta-analysis. [PDF]
Jiang Y +9 more
europepmc +1 more source
First Successful Treatment Reported with Pembrolizumab in a Patient Diagnosed with Choriocarcinoma in Hungary. [PDF]
Lakatos KF +4 more
europepmc +1 more source
Application and mechanistic research of novel therapeutic strategies in cisplatin-resistant small cell lung cancer. [PDF]
Chen Z +11 more
europepmc +1 more source
Insulin-stimulated glucose uptake is impaired in senescent human adipocytes. [PDF]
Alexandersson I +4 more
europepmc +1 more source
Etoposide activates CD8<sup>+</sup> T cell anti-tumor immunity in osteosarcoma through MHC I upregulation via tumor-secreted IL-33 mediated signaling. [PDF]
He X +20 more
europepmc +1 more source
Senescent Factors Suppress Innate Antiviral Immunity in Aged Mice via Two Distinct Mechanisms. [PDF]
Zhang X, Zhang Q, Wang L, Li S, Shu HB.
europepmc +1 more source
Retraction: A phase II, single-arm study of apatinib and oral etoposide in heavily pre-treated metastatic breast cancer. [PDF]
Frontiers Editorial Office.
europepmc +1 more source
End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy-Modified N7 Regimen with Dinutuximab Beta. [PDF]
Lu ER +13 more
europepmc +1 more source
Crosstalk between TGF-β and Wnt/β-catenin signaling drives fibrogenic and stem-like phenotypes in senescent MDA-MB-231 breast cancer cells. [PDF]
El Samarji M +7 more
europepmc +1 more source
Mogamulizumab plus etoposide in the management of mycosis fungoides with blood involvement: a case report. [PDF]
Rodríguez DN, Sendagorta E.
europepmc +1 more source

